sb-269970 and Prostatic-Neoplasms

sb-269970 has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for sb-269970 and Prostatic-Neoplasms

Article	Year
5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues. Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:6 Topics: Apoptosis; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; PC-3 Cells; Phenols; Piperazines; Prostatic Neoplasms; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Tetrahydronaphthalenes; Time Factors	2021

Article

Year

5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues.

Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:6

Topics: Apoptosis; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; PC-3 Cells; Phenols; Piperazines; Prostatic Neoplasms; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Tetrahydronaphthalenes; Time Factors

2021